Search

Background Toxoplasma gondii is a protozoan with worldwide distribution and triggers a strong Th1 immune response in infected susceptible hosts. On the contrary, most helminth infections are characterized by Th2 immune response and the use of helminth-derived antigens to regulate immune response in inflammatory disorders has been broadly investigated. Objectives The aim of this study was to investigate whether treatment with Strongyloides venezuelensis antigen extract (SvAg) would alter immune response against T. gondii. Methods C57BL/6 mice were orally infected with T. gondii and treated with SvAg, and parasitological, histological and immunological parameters were investigated. Results It was observed that SvAg treatment improved survival rates of T. gondii infected mice. At day 7 post-infection, the parasite load was lower in the lung and small intestine of infected SvAg-treated mice than untreated infected mice. Remarkably, SvAg-treated mice infected with T. gondii presented reduced inflammatory lesions in the small intestine than infected untreated mice and decreased intestinal and systemic levels of IFN-γ, TNF-α and IL-6. In contrast, SvAg-treatment increased T. gondii-specific IgA serum levels in infected mice. Conclusions S. venezuelensis antigen extract has anti-parasitic and anti-inflammatory properties during T. gondii infection suggesting as a possible alternative to parasite and inflammation control.